Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Exact Sciences Q4 Revenues up 58 Percent; Company to Acquire Ashion Analytics From TGen

Exact Sciences Q4 Revenues up 58 Percent; Company to Acquire Ashion Analytics From TGen

Feb 16, 2021
|
staff reporter

NEW YORK – Exact Sciences reported after the close of the market on Tuesday that its fourth quarter revenues rose 58 percent year over year, in line with preliminary results announced last month. Revenues from cancer screening, the firm's largest business segment, increased 9 percent during the quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Mix of Human and Monkey

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

Fetal Tissue Policy Changes Expected

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

Science Papers on Approach to Isolate DNA from Sediment, Algorithm to Construct Signaling Networks

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Sequencing the Zoo

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.

What's Popular?

In Business News

  1. Thermo Fisher Scientific to Acquire Contract Research Organization PPD for $17.4B

  2. Cancer Dx Firm C2i Genomics Raises $100M in Financing

  3. With Luminex Acquisition, DiaSorin to Broaden MDx Portfolio, Expand US Presence

    Premium

  4. Color Health, Yale Get FDA Emergency Use Authorization for Coronavirus Sample Collection Kits

  5. Invitae, PCT Therapeutics, Genome Medical Partner to Offer Genetic Testing for Cerebral Palsy

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.